Table 1.

General characteristics and medical history.

	BNT162b2 mRNA (%)	mRNA-1273 (%)	Gam-COVID-Vac (%)	Coronavac (%)	ChAdOx1-S (%)	Ad5-nCoV (%)	Ad26.COV2 (%)	p-value
Total	289	65	200	582	666	19	31
Obesity	54 (18.6)	11 (16.9)	44 (22)	188 (32.3)	248 (37.2)	8 (42.1)	6 (19.3)	<0.001
Smoker	37 (12.8)	10 (15.3)	27 (13.5)	60 (10.3)	38 (5.7)	2 (10.5)	2 (6.4)	0.001
Hypertension	36 (12.4)	2 (3)	77 (38.5)	116 (19.9)	265 (39.7)	3 (15.7)	2 (6.4)	<0.001
Dyslipidemia	27 (9.3)	3 (4.6)	55 (27.5)	76 (13.5)	150 (22.5)	1 (5.2)	1 (3.2)	<0.001
Type2 Diabetes	13 (4.4)	1 (1.5)	32 (16)	78 (13.4)	164 (24.6)	0	0	<0.001
Asthma	9 (3.1)	3 (4.6)	6 (3)	13 (2.3)	17 (2.5)	0	0	0.79
Other autoimmune disease such as thyroiditis or psoriasis	9 (3.1)	0	4 (2)	29 (4.9)	60 (9)	1 (5.2)	1 (3.2)	<0.001
Rheumatoid arthritis	7 (2.4)	1 (1.5)	16 (8)	11 (1.8)	56 (8.4)	0	1 (3.2)	<0.001
Surgery in the last year	6 (2)	0	6 (3)	26 (4.4)	45 (6.7)	3 (15)	1 (3.2)	0.002
Previous Cancer	5 (1.7)	1 (1.5)	1 (0.5)	5 (0.8)	29 (4.3)	0	0	0.001
NAFLD	4 (1.3)	0	7 (3.5)	27 (4.6)	21 (3.1)	2 (10.5)	0	0.042
Immunosuppressive treatment	4 (1.3)	0	3 (1.5)	6 (1)	11 (1.6)	0	0	0.86
Other liver disease	3 (1)	0	10 (5)	10 (1.7)	10 (1.5)	0	0	0.02
End stage renal disease	2 (0.7)	0	2 (1)	3 (0.5)	11 (1.6)	0	0	0.44
Pregnancy	2 (0.7)	1 (1.5)	0	3 (0.5)	0	1 (5.2)	0	0.005
Cirrhosis	2 (0.7)	0	0	2 (0.3)	4 (0.6)	0	0	0.88
Pulmonar Obstructive Chronic Disease	1 (0.3)	0	3 (1.5)	4 (0.6)	8 (1.2)	0	0	0.68
Coronary heart disease	1 (0.3)	0	15 (7.5)	3 (0.5)	23 (3.4)	0	0	<0.001
Gout	1 (0.3)	0	10 (5)	19 (3.2)	27 (4.05)	0	0	0.02
Active Cancer	0	0	1 (0.5)	1 (0.17)	10 (1.5)	0	0	0.054
Atrial Fibrilation	0	0	13 (6.5)	6 (1)	36 (5.4)	0	0	0.001
Congestive heart failure	0	0	18 (9)	1 (0.2)	12 (1.8)	0	0	0.001
Stroke	0	0	2 (1)	1 (0.2)	13 (1.9)	0	0	0.01
Trasplant	0	0	0	3 (0.5)	5 (0.7)	0	0	0.63
Pregnancy	2	1	0	3 (0.5)	0	1 (5.2)	0	0.05

Table 1 shows the medical history and comparison between vaccine groups, p<0.05 was considered statistically significant.